Facilitating a More Efficient Commercial Review Process for Pediatric Drugs and Biologics

Over the past two decades, the biopharmaceutical industry has seen unprecedented expansion and innovation in concert with significant technological advancements. While the industry has experienced marked growth, the regulatory system in the United States still operates at a capacity much lower than...

Descripción completa

Detalles Bibliográficos
Autores principales: Rykhus, Ryan D., Shepard, Zachary V., Young, Alix, Frisby, Hadley, Calder, Kailee A., Coon, Collin M., Falk, Justin A., McAndrews, Sydney R., Turner, Aspen, Chang, Christina, Michelsohn, Johanna, Petch, Raegan, Dieker, Sarah M., Markworth, Benjamin H., Alamo-Perez, Kevin, Hosack, Aaron J., Berg, Jacob M., Schmidt, Christian, Storsberg, Joachim, Brown, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 0201
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871948/
https://www.ncbi.nlm.nih.gov/pubmed/29271878
http://dx.doi.org/10.3390/diseases6010002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871948/
https://www.ncbi.nlm.nih.gov/pubmed/29271878
http://dx.doi.org/10.3390/diseases6010002

Ejemplares similares